4.6 Article

Identifying women who may benefit from higher dose omega-3 supplementation during pregnancy to reduce their risk of prematurity: exploratory analyses from the ORIP trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Recent advances in policy and practice translation of the evidence for additional omega-3 fatty acids and prematurity

Lucy A. Simmonds et al.

Summary: This review summarizes the latest research on the effectiveness of omega-3 fatty acids in reducing the risk of premature birth. The findings suggest that screening and providing appropriate advice can effectively reduce the risk of early preterm birth.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2022)

Article Biochemistry & Molecular Biology

Translating n-3 polyunsaturated fatty acid status from whole blood to plasma and red blood cells during pregnancy Translating n-3 status across blood fractions in pregnancy

Lucy A. Simmonds et al.

Summary: Women with low n-3 status in pregnancy can reduce their risk of early preterm birth through LCPUFA supplementation. Equations are developed to compare fatty acid status across different blood fractions. Whole blood or plasma can be used to define low n-3 status in pregnancy.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2022)

Article Medicine, General & Internal

Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial

Susan E. Carlson et al.

Summary: This study suggests that during pregnancy, 1000 mg of DHA per day is more effective in reducing the rate of early preterm birth compared to 200 mg for women with low DHA status. Additionally, the higher dose is associated with fewer serious adverse events.

ECLINICALMEDICINE (2021)

Article Obstetrics & Gynecology

Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial

L. A. Simmonds et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)

Review Biochemistry & Molecular Biology

Influence of clinical characteristics on maternal DHA and other polyunsaturated fatty acid status in pregnancy: A systematic review

N. A. Wilson et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2020)

Letter Public, Environmental & Occupational Health

n-3 and preterm birth: what can we learn from the heterogeneity?

Timothy H. Ciesielski

PUBLIC HEALTH NUTRITION (2020)

Review Biochemistry & Molecular Biology

Gestational age and maternal status of DHA and other polyunsaturated fatty acids in pregnancy: A systematic review

Nina A. Wilson et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2019)

Article Medicine, General & Internal

A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery

Maria Makrides et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Medicine, General & Internal

Omega-3 fatty acid addition during pregnancy

Philippa Middleton et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Article Obstetrics & Gynecology

Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol

Susan E. Carlson et al.

BMC PREGNANCY AND CHILDBIRTH (2017)

Article Substance Abuse

Prenatal Alcohol Consumption Between Conception and Recognition of Pregnancy

Clare McCormack et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2017)

Article Health Care Sciences & Services

A re-randomisation design for clinical trials

Brennan C. Kahan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2015)

Article Obstetrics & Gynecology

Predictors of antenatal alcohol use among Australian women: a prospective cohort study

A. E. Anderson et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)

Article Mathematical & Computational Biology

Improper analysis of trials randomised using stratified blocks or minimisation

Brennan C. Kahan et al.

STATISTICS IN MEDICINE (2012)